Latest Insider Transactions at Lipella Pharmaceuticals Inc (LIPO)
This section provides a real-time view of insider transactions for Lipella Pharmaceuticals Inc (LIPO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LIPELLA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LIPELLA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2024
|
Jonathan H Kaufman Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.1%
|
$0
$0.76 P/Share
|
|
Mar 19
2024
|
Jonathan H Kaufman Director |
BUY
Open market or private purchase
|
Direct |
25,000
+2.74%
|
$0
$0.87 P/Share
|
|
Mar 18
2024
|
Jonathan H Kaufman Director |
BUY
Open market or private purchase
|
Direct |
30,000
+3.36%
|
$0
$0.79 P/Share
|
|
Mar 13
2024
|
Jonathan H Kaufman Director |
BUY
Grant, award, or other acquisition
|
Direct |
144,906
+14.81%
|
$0
$0.69 P/Share
|
|
Mar 13
2024
|
Michael B Chancellor Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144,906
+14.17%
|
$0
$0.69 P/Share
|
|
Dec 22
2022
|
Michael B Chancellor Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
22,950
+3.04%
|
$114,750
$5.75 P/Share
|